DCN Dx, a specialist in diagnostics development, manufacturing, regulatory consulting, and clinical research, today announced the launch of a new prospective biospecimen collections offering, ...
On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...
The ISPOR Glasgow panel conveyed a constructive, forward looking mood: JCA can work – and work better over time – if ...
GlobalData on MSN
MSD begins KANDLELIT-007 trial of calderasib for NSCLC
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
Union argued requirement contradicted collective agreement, disproportionately affected employees on maternity leave ...
The regulator has stripped out some data points from its proposed value assessments and put forward a more nuanced four-point ...
Palmer brings claims under the Age Discrimination in Employment Act and for wrongful termination in violation of North ...
Financial Conduct Authority (FCA), and The Pensions Regulator (TPR) have launched a consultation on the value for money (VfM) ...
There was widespread support from the industry for the new value for money framework set out by the Department of ...
The Department of Work & Pensions, the Financial Conduct Authority and The Pensions Regulator have proposed key changes to ...
An active comparator observational study concludes that avoiding NSAIDs and choosing acetaminophen because of potential VTE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback